السلام عليكم
سعر السهم بالامس 12.67
الان 3.25
رابط الخبر
http://biz.yahoo.com/bw/060203/20060203005252.html?.v=1
بالتوفيق
سعر السهم بالامس 12.67
الان 3.25
رابط الخبر
http://biz.yahoo.com/bw/060203/20060203005252.html?.v=1
MIRA-1 did not demonstrate a statistically significant difference in the mean change of Best Spectacle-Corrected Visual Acuity applying the Early Treatment Diabetic Retinopathy Scale ("ETDRS BCVA") between the treated and placebo groups at 12-months post-baseline. As expected, the treated group demonstrated a positive response. An anomalous response of the control group is the principal reason that the primary efficacy endpoint was not met.
بالتوفيق